Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Equal-Weight on Hillman Solns, Lowers Price Target to $9

Author: Benzinga Newsdesk | July 12, 2024 11:44am
Barclays analyst Matthew Bouley maintains Hillman Solns (NASDAQ:HLMN) with a Equal-Weight and lowers the price target from $10 to $9.

Posted In: HLMN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist